Approval · Notice of Compliance 8866 · 2007
LUCENTIS: Notice of Compliance 8866
Issued June 26, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8866
- Date
- June 26, 2007
- Company
- Novartis Ophthalmics Novartis Pharmaceuticals (Canada) IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Anti-neovascularisation agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LUCENTIS | 02296810 | Marketed |
Medicinal ingredients
- RANIBIZUMAB 10 MG per ML